BioNTech on track for a catalyst-rich year with six late-stage data readouts expected across immunomodulators, antibody-drug conjugates and mRNA cancer immunotherapies Increased focus on PD-L11/VEGF-A ...
Link: The near-term outlook for the Zacks Domestic Auto industry appears somewhat subdued. Sales momentum has weakened in recent months as high vehicle prices and economic uncertainty make consumers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results